Protocol for a large-scale prospective observational study with alogliptin in patients with type 2 diabetes: J-BRAND Registry (Q34198223)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227623%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

title

Protocol for a large-scale prospective observational study with alogliptin in patients with type 2 diabetes: J-BRAND Registry (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227623%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227623%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Hirotaka Watada

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227623%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Yukio Tanizawa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227623%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Jiro Nakamura

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227623%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Yuichiro Yamada

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227623%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Iichiro Shimomura

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227623%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Rimei Nishimura

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227623%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Tsutomu Yamazaki

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227623%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Takashi Kadowaki

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227623%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Kohjiro Ueki

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227623%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

publication date

16 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227623%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227623%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227623%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227623%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

e004760

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227623%20AND%20SRC:MED&resulttype=core&format=json

Type 2 diabetes mellitus: a review of current trends

16 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166248

Potent antiatherosclerotic effects of alogliptin in addition to its potent antidiabetic effects

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166248

Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166248

Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166248

Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166248

Using data mining techniques to explore physicians' therapeutic decisions when clinical guidelines do not provide recommendations: methods and example for type 2 diabetes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166248

Recent advances in the management of type 2 diabetes mellitus: a review.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166248

Sitagliptin: a novel agent for the management of type 2 diabetes mellitus

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166248

Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166248

Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166248

Chronic administration of alogliptin, a novel, potent, and highly selective dipeptidyl peptidase-4 inhibitor, improves glycemic control and beta-cell function in obese diabetic ob/ob mice

28 July 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2013-004760

Tolerability of dipeptidyl peptidase-4 inhibitors: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2013-004760

Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non-diabetic subjects: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2013-004760

Dipeptidyl peptidase-4 inhibitors attenuate endothelial function as evaluated by flow-mediated vasodilatation in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2013-004760

Acute pancreatitis in type 2 diabetes treated with exenatide or sitagliptin: a retrospective observational pharmacy claims analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2013-004760

10.1136/BMJOPEN-2013-004760

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227623%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227623%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25227623%20AND%20SRC:MED&resulttype=core&format=json